Mycobacterial phthiocerol dimycocerosate induces Galectin-3 upregulation to impair proinflammatory responses and favor immune evasion.

分枝杆菌邻苯二酚二霉菌酸酯诱导半乳糖凝集素-3上调,从而损害促炎反应并有利于免疫逃逸

阅读:16
作者:Wang Hankun, Li Dan, Song Li, Zhou Chao, Huang Xinhua, Huang Weifeng, Zhang Ding, Ding Cairong, Song Jingrui, Zhou Shuang, Luo Chunyan, Xia Xuan, Gonzales Jacqueline, Via Laura E, Wang Decheng
Mycobacterium tuberculosis, a typical intracellular parasite that causes tuberculosis, is ranked as the top infectious killer for humans in annual WHO reports. Pathogenic mycobacterium has evolved numerous strategies to favor their intracellular survival including a unique lipid-rich-cell-wall and granuloma formation during infection. Phthiocerol dimycocerosate (PDIM) is a critical virulence factor of mycobacteria including Mycobacterium marinum (Mm), which manipulate host immune responses and granuloma induction and facilitate immune evasion, but the mechanisms still remain unclear. We used an AACT/SILAC-based-quantitative proteomic approach to determine PDIM-responsive proteomics during Mm-infection. A major difference was the high abundance of Gal-3 in WT_Mm-infected cells not observed in PDIM-deficient infections. Gal-3 induction by PDIM-replete bacteria was primarily via Toll-like-receptor 2, and also engaged TGF-β non-classical-pathway. Elevated Gal-3 in macrophages prevented the turnover and translocation of NF-κB to effectively modulate the profile of inflammatory cytokines. Gal-3 Silencing effectively reduced tissue damage induced in mice by PDIM-expressing Mm. We found upregulated Gal-3 in the serum and BALF of clinical tuberculosis cases, which decreased significantly after effective chemotherapy. Our findings demonstrated that upregulated Gal-3 not only plays an important role in regulating host immune response and granuloma formation, but also suggests that targeting-Gal-3 therapy could be a promising anti-tuberculosis strategy.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。